Engineered CD47 protects T cells for enhanced antitumour immunity

Overview of attention for article published in Nature, May 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
twitter: 73 X users

wikipedia: 1 Wikipedia page
bluesky: 1 Bluesky user

Readers on

mendeley: 111 Mendeley

So far, Altmetric has seen 76 X posts from 73 X users, with an upper bound of 2,909,164 followers.

RT @jyasuda1: きちんとわかっていないが固形がんなどを標的としたCAR-Tの設計に際し、CD47を改変することで抗CD47抗体を同時に添加しても宿主マクロファージによる貪食を回避、導入細胞を長く維持することに成功したという論文らしい。Nature。 https://…

マクロファージ活性化症候群など診てる身からすると興味深すぎる🤔 "CAR-Tの設計に際し、CD47を改変することで抗CD47抗体を同時に添加しても宿主マクロファージによる貪食を回避、導入細胞を長く維持"

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 72 additional X posts.